CDK7 and breast cancer: In contrast to the specific downregulation of intracellular accumulation of mutated p53 by CDK7 inhibition in TNBC cells, our data also show that CDK7 inhibitor treatment could elevate the expression of p53 in breast cancer cells with wild-type p53 (Figures 2, 3).